Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Côlon ou Rectum (colorectal)
- | Specialty :
- Chimiothérapie
- Thérapies Ciblées
Extract
A randomized, open-label phase II study evaluating the efficacy and safety of FOLFOX-4 plus cetuximab versus UFOX plus cetuximab as first-line therapy in subjects with metastatic colorectal cancer.
Scientific Abstract
en cours d'intégration;